News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study



1/19/2012 7:21:26 AM

SANTA ROSA, Calif.--(BUSINESS WIRE)--Sapheon Inc. announced one year results in its first in-man safety trial of the Sapheon Closure System. At the one year mark, 100% of the great saphenous vein segments treated with the company’s novel proprietary vein sealant remained completely closed by ultrasound criteria. All patients reported significant improvement in symptoms compared to baseline. No device or procedure related serious adverse events occurred at any interval over the follow-up period.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES